In addition, when surviving mice (n = 7 bintrafusp alfa-treated and n = 3 anti-PD-L1-treated) were rechallenged with A223 cells s.c. 147 days after initial tumor cell transplantation, none grew tumors within 80 days, while a cohort of naïve mouse recipients rapidly developed tumors and reached survival endpoints within 30 days (Fig. 1g). The gene discussed is CD274; the disease is neoplasm.